Abstract S103. EFFICACY AND SAFETY OF ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR-T CELL THERAPY WITH FRACTIONATED INITIAL THERAPY AND BOOSTER DOSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
Dr Carlos Fernandez de Larrea, Hospital Clínic de Barcelona, Barcelona, Spain
Recorded @ Vienna Messe Center, June 11, 2022